Top Markets
Coin of the day
AREV Life Sciences Global Corp. AREV Life Sciences Global Corp.

AREV Life Sciences Global Corp.

AREV
Hisse Senetlerindeki Sıralama #37036
AREV Life Sciences Global Corp., established in Coquitlam, Canada in 2005,... AREV Life Sciences Global Corp., established in Coquitlam, Canada in 2005, operates as an integrated life science discovery firm, focusing on the development and sale of functional ingredients throughout Canada. Its diverse product line includes various CBD-infused items like the anti-viral supplements Canna-Mulsion and NaturVax, NaturRelax for natural sleep support, and Natur Relief, designed for anti-inflammatory and pain relief. Additionally, the company provides white-label cannabis products, a selection of THC offerings, cannabis-based skincare, and medicinal oils and edibles. These specialized ingredients are utilized in products intended for the natural health, medical, functional food, nutraceutical, sports nutrition, and bioceutical industries. AREV's solutions target health concerns such as sleep deprivation, insomnia, anxiety, pain, and inflammatory conditions, alongside other specific ailments. The company also offers nutraceutical formulations under its Bare brand and ready-to-use therapeutic food products named SUS-TAINN. Formerly known as AREV NanoTec Brands Inc., the company officially adopted its current name in August 2021.
Hisse Fiyatı
$0.06605432
Son senkronizasyon: 2024-07-23
Piyasa Değeri
$2.08M
Değişim (1 gün)
-2.93%
Değişim (1 yıl)
0.00%
Ülke
CA
Ticaret AREV Life Sciences Global Corp. (AREV)

Kategori

AREV Life Sciences Global Corp. (AREV) için EPS
2026 itibariyle EPS TTM: 0
AREV Life Sciences Global Corp. şirketinin en son finansal raporlarına ve hisse senedi fiyatına göre, şirketin mevcut EPS'si (TTM) 0'dir. 2026 yılı sonunda, şirketin EPS'si 0 idi; bu, 2026 yılındaki EPS olan 0 ile önceki yıla eşit.
AREV Life Sciences Global Corp. için 2026 - 2026 arasındaki EPS geçmişi
Her yıl sonunda EPS
Yıl EPS Değiştir
Sağlanan tarihler için yeterli veri yok.